Betz Stephen F.

Betz Stephen F. is listed in filings as Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX). This profile follows SEC Form 4 activity through Mar 18, 2026, including sale activity. Recent filings connect the profile to Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). The current snapshot covers public activity from Jun 11, 2024 to Mar 18, 2026. Reported amounts are shown as $236.4K to $2.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.